Marathon Rotary Club

Wednesday, 12:15pm Meeting at the Marathon Yacht Club


The subcutaneous program utilizes a fresh formulation of ORENCIA.

Bristol Myers-Squibb includes a comprehensive development program underway to evaluate the potential subcutaneous administration of ORENCIA through an injection into the epidermis in adults with moderate to serious rheumatoid arthritis safety guide . ORENCIA is already available for the treatment of adults with moderate to severe rheumatoid arthritis. The subcutaneous program utilizes a fresh formulation of ORENCIA, which includes been designed for subcutaneous administration specifically. Related StoriesAbbVie reports positive results from ABT-494 Phase 2 medical trials in patients with rheumatoid arthritisNovel modular partial wrist implant may provide relief for individuals with painful wrist arthritisScientists identify brand-new protein that regulates severity of tissue damage due to RAThese data, from a 4-month open-label trial involving 100 patients, were presented today at the American College of Rheumatology Annual Scientific Interacting with.